What are the best treatments for Sly Syndrome?

Sly syndrome, also known as Mucopolysaccharidosis type VII (MPS VII), is primarily managed through enzyme replacement therapy and supportive care tailored to specific organ system involvement. Because Sly syndrome is a progressive metabolic disorder, treatment focuses on stabilizing symptoms and improving quality of life through a multidisciplinary medical approach.

What are the primary medical treatments for Sly syndrome?

The cornerstone of pharmacological intervention for Sly syndrome is enzyme replacement therapy (ERT) using vestronidase alfa (Mepsevii). This medication provides the missing beta-glucuronidase enzyme, which helps break down glycosaminoglycans (GAGs) that otherwise accumulate in tissues. While ERT is effective for managing many systemic symptoms, it does not typically cross the blood-brain barrier, meaning some neurological manifestations of Sly syndrome may persist.

What supportive and non-pharmacological therapies are used?

Because Sly syndrome affects multiple organ systems, care plans often include a combination of surgical and rehabilitative therapies. Treatment effectiveness varies significantly between patients depending on the severity of the genetic mutation and the age at which therapy begins. Common supportive interventions include:

• Physical and Occupational Therapy: Essential for managing joint contractures and maintaining mobility.


• Surgical Intervention: Procedures such as hernia repair, carpal tunnel release, or orthopedic surgeries to correct skeletal deformities.


• Respiratory Support: Use of sleep apnea management (CPAP) or supplemental oxygen if pulmonary function is compromised.


• Cardiac Monitoring: Regular echocardiograms to track valve function and heart health.

Which specialists should be on the care team?

Managing Sly syndrome requires a coordinated team of specialists to address the multisystemic nature of the condition. Your care team should ideally include a metabolic geneticist, a cardiologist, an orthopedic surgeon, a pulmonologist, and a physical therapist. Regular assessments by these professionals ensure that treatment for Sly syndrome remains responsive to the patient's evolving clinical needs.

Next steps

• Consult with a board-certified metabolic geneticist to establish a baseline care plan.


• Connect with the National MPS Society to access resources and patient support networks.


• Ask your physician about active clinical trials for Sly syndrome via ClinicalTrials.gov.

Medical disclaimer: This information is for educational purposes and does not replace professional medical advice; always consult your personal healthcare team for treatment decisions.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Mucopolysaccharidosis type VII


• Orphanet: Mucopolysaccharidosis type VII


• OMIM (Online Mendelian Inheritance in Man): Beta-Glucuronidase Deficiency


• National MPS Society: MPS VII Patient Resources